TRVN trevena.com: Rasio nilai perusahaan marang pendapatan

Challenges in bringing new analgesics to market are putting pressure on the business of Trevena, Inc. (TRVN). Bankruptcy risks and the slow rollout of Olinvyk are complicating the company's financial position. The EV/Sales multiple reflects capitalization dynamics relative to revenue, with the current metric standing at . Simultaneously, Trevena, Inc. (TRVN) is implementing ESG standards by transitioning to eco-friendly packaging and closed-loop water systems at its plants.
TRVN (Trevena, Inc): rincian analitis lan laporan miturut indikator

To isolate the fundamental stability of Trevena, Inc. (TRVN) from market noise, it is necessary to compare the total enterprise value with sales volume, excluding the impact of debt. By analyzing the EV/Sales ratio on the GURU.Markets platform, an investor assesses the efficiency of revenue capitalization, which Trevena, Inc. (TRVN) optimizes through the implementation of automated clinical data processing systems to enhance research accuracy.